If you've had radiation for throat cancer, you know dry mouth isn't just uncomfortable — it can make eating, talking, and sleeping miserable. Now a new study shows a more targeted radiation technique may spare your saliva glands without hurting your chances of beating the cancer.
Researchers followed 266 people with nasopharyngeal carcinoma who received a type of radiation called comprehensive salivary gland–sparing helical tomotherapy. After a median of nearly six years, only one person (0.4%) developed severe dry mouth (Grade III). Mild to moderate dry mouth occurred in 9.8% of patients. That's far lower than rates seen with older radiation methods.
And here's the good news: the cancer outcomes were excellent. Five-year overall survival was 81.6%, and cancer-specific survival reached 90.2%. The locoregional recurrence rate was just 7.5%. No serious acute or late side effects were seen. The study did find that age was linked to survival — older patients had slightly lower survival odds — but the treatment itself appeared safe and effective across the group.
This isn't a cure-all, and the results come from a single group of patients. But for anyone facing radiation for nasopharyngeal cancer, this technique offers real hope for preserving quality of life without sacrificing cancer control.
